ASGCT News

28th Annual Meeting Registration Is Open

Secure your spot in New Orlenas May 13-17! | December 03, 2024

Join us in New Orleans May 13-17 for the largest gathering of CGT professionals at the 28th Annual Meeting! 

Annual Meeting 2025

Read Full Story

Single-chain Antibody-directed Herpes Simplex Viruses with Joseph Glorioso, PhD

Listen to The Molecular Therapy Podcast | December 03, 2024

In this episode, Dr. Timothy Cripe and Dr. Joseph Glorioso discuss an article published in Molecular Therapy Oncology by Dr. Glorioso and colleagues, Oncolytic Herpes Simplex Viruses Designed for Targeted Treatment of EGFR-bearing Tumors.

Podcasts

Read Full Story

ASGCT-AAAS Congressional Policy Fellow Reflects on First Weeks

Adriana Bankston, PhD | November 19, 2024

Learn what the first few weeks of the Congressional Policy Fellowship have been like for Dr. Adriana Bankston and apply for next year's fellowship through Feb. 24.

Policy & Advocacy

Read Full Story

Breakthroughs in Muscular Dystrophy Conference Networking Tips

Use these networking tips to connect with colleagues next week! | November 15, 2024

Here are some tips for making the most out of our upcoming muscular dystrophy conference.

Read Full Story

Here's What to Know Before #ASGCTBreakthroughs24

There's still time to register to join us Tuesday! | November 15, 2024

Here's what you should know before attending next week's Breakthroughs in Muscular Dystrophy conference on site in Chicago or virtually.

Read Full Story

FDA Approves First Gene Therapy for AADC Deficiency

Paula Cannon, PhD | November 14, 2024

FDA approved Kebilidi (eladocagene exuparvovec), the first approved gene therapy in the U.S. to be directly administered into the brain.

Cell & Gene Therapy Approval

Read Full Story

CBER Wants to Ensure Patient Voice Remains Central to Gene Therapy Development

Allison Bradbury, PhD, Lauren Beretich, PhD, MS, CGC, and Yulia Grishchuk, PhD | November 13, 2024

Check out this recap from Patient Outreach Committee members about a recent FDA patient listening session.

Read Full Story

cGMP and Building Cohesive Teams with Christopher Choi, PhD

Listen to the new episode! | November 12, 2024

This wide-ranging conversation covers cell therapy development and manufacturing and how the growing Roswell Park Center is aiming to support sponsors in the CAR T and cell therapy space.

Read Full Story

FDA Approves Obe-cel for B-Cell Acute Lymphoblastic Leukemia (ALL)

Paula Cannon, PhD | November 11, 2024

On Friday, Nov. 8, FDA approved obe-cel for B-cell acute lymphoblastic leukemia (ALL).

Cell & Gene Therapy Approval

Read Full Story

A New Era of Molecular Therapy with Joseph Glorioso, PhD

Listen to the episode now. | November 06, 2024

This episode features a conversation between Dr. Roland Herzog and Dr. Joseph Glorioso.

Molecular Therapy  |  Podcasts

Read Full Story

Now Available: Breakthroughs in Muscular Dystrophy Abstracts

Read + download the full abstracts collection, and register if you haven't already! | November 04, 2024

View and download the latest gene and cell therapy research for muscular dystrophy.

Read Full Story

Breakthroughs in Muscular Dystrophy is Two Weeks Away

Register to join us in Chicago or online. | October 28, 2024

Join ASGCT and the Muscular Dystrophy Association on November 19-20, at The Westin Michigan Avenue Chicago or online, for an unparalleled opportunity to explore the latest advancements in gene and cell therapies for muscular dystrophy.

Read Full Story

Collaboration and Innovation at the Policy Summit: Paving the Way for Patient Access to CGTs

Daniela Drago, PhD | October 25, 2024

The 2024 ASGCT Policy Summit, held in Washington, D.C., brought together key stakeholders from across the cell and gene therapy (CGT) landscape. The central theme? Collaborative innovation.

Policy & Advocacy  |  Policy Summit

Read Full Story

Read the ASGCT-Citeline 2024 Q3 Landscape Analysis Field Report

Read + download the full report | October 24, 2024

In Q3, Tecelra was approved for adults with metastatic synovial sarcoma, newly initiated gene therapy trials increased for non-oncology indications, and seed and Series A funding nearly doubled.

Read Full Story

Non-AAV, Non-rare Gene Therapy with Derek Jackson

Listen to the latest episode of The Issue | October 15, 2024

Derek Jackson, vice president of cell and gene therapy product development at Pacira BioSciences, joins The Issue to take the program in a different direction.

Podcasts

Read Full Story